Apelin, Prediabetes and Atherosclerosis

I. Tasci

doi:10.1055/s-0031-1284338

Experimental and Clinical Endocrinology & Diabetes, Inhaltsverzeichnis

Exp Clin Endocrinol Diabetes 2011; 119(08): 457-458
DOI: 10.1055/s-0031-1284338

Letter to the Editor

Georg Thieme Verlag KG Stuttgart · New York

Apelin, Prediabetes and Atherosclerosis

I. Tasci

¹Department of Internal Medicine, Gulhane School of Medicine, Turkey

References
1 Bots ML, Westerink J, Rabelink TJ et al. Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response. Eur Heart J 2005; 26: 363-368
2 Erdem G, Dogru T, Tasci I et al. Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2008; 116: 289-292
3 Graham I, Atar D, Borch-Johnsen K et al. European Society of Cardiology (ESC); European Association for Cardiovascular Prevention and Rehabilitation (EACPR); Council on Cardiovascular Nursing; European Association for Study of Diabetes (EASD); International Diabetes Federation Europe (IDF-Europe); European Stroke Initiative (EUSI); International Society of Behavioural Medicine (ISBM); European Society of Hypertension (ESH); European Society of General Practice/Family Medicine (ESGP/FM/WONCA); European Heart Network (EHN). European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007; 14 (Suppl. 02) E1-E40
4 Lucio M, Fekete A, Weigert C et al. Insulin sensitivity is reflected by characteristic metabolic fingerprints – a Fourier transform mass spectrometric non-targeted metabolomics approach. PLoS One 2010; 5: e13317
5 Radikova Z, Koska J, Huckova M et al. Insulin sensitivity indices: a proposal of cut-off points for simple identification of insulin-resistant subjects. Exp Clin Endocrinol Diabetes 2006; 114: 249-256
6 Ringström C, Nitert MD, Bennet H et al. Apelin is a novel islet peptide. Regul Pept 2010; 162: 44-51
7 Rittig K, Hildebrandt U, Thamer C et al. Apelin Serum Levels are not Associated with Early Atherosclerosis or Fat Distribution in Young Subjects with Increased Risk for Type 2 Diabetes. Exp Clin Endocrinol Diabetes 2011;
8 Sonmez A, Celebi G, Erdem G et al. Plasma apelin and ADMA Levels in patients with essential hypertension. Clin Exp Hypertens 2010; 32: 179-183
9 Tasci I, Dogru T, Naharci I et al. Plasma apelin is lower in patients with elevated LDL-cholesterol. Exp Clin Endocrinol Diabetes 2007; 115: 428-432
10 Zhang Y, Shen C, Li X et al. Low plasma apelin in newly diagnosed type 2 diabetes in Chinese people. Diabetes Care 2009; 32: e150